NCT00701935 - Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Diabetes Mellitus

Interventions

DRUG

placebo

subcutaneous injection, twice a day

DRUG

exenatide

subcutaneous injection, twice a day, 10mcg

Trial Locations (17)

Research Site, Temple

Research Site, Colorado Springs

Research Site, Honolulu

Research Site, Bellevue

Research Site, Las Vegas

Research Site, Calgary

Research Site, Vancouver

Research Site, Victoria

Research Site, Winnipeg

Research Site, Saint John

Research Site, Brampton

Research Site, London

Research Site, Ottawa

Research Site, Toronto

Research Site, Chicoutimi

Research Site, Pointe-Claire

Research Site, Québec